Virtual Symposium:
Digital Pathology
15 October 2020 | PDT (UTC -7)

Hear from and meet with the leading figures in the digital pathology field and benefit from in-depth discussion of the advantages and challenges of utilising digital pathology in different therapeutic areas

The programme brings together international pharmaceutical organisations, leading biotech companies and globally renowned academic institutions specialising in digital pathology tools and tissue image analysis.

It includes over 10 cutting-edge presentations and over 8 hours of valuable networking session through our immersive digital platform.

Download Agenda

Full details for Virtual Symposium: Digital Pathology, including presentations, topic areas and confirmed speakers, can be found in the Conference Brochure.

Book Online

Registration for Virtual Symposium: Digital Pathology is now open. Please click the button below.

LinkedIn Group

Our LinkedIn group aims to foster discussion and collaboration between experts working in pathology, biomarker development and translational research.

Virtual Symposium:
Digital Pathology

is sponsored by

Programme

The Virtual Symposium: Digital Pathology includes...

Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working within digital pathology, tissue image analysis and biomarker development.

  • Hear from and meet with the leading figures in the digital pathology field, offering in-depth presentations and new ideas you can use to advance your research
  • Interact with fellow attendees and speakers through the networking features of the Event App as well as during live Q&As at the end of each presentation
  • Discover advancements in Digital Pathology through a review of the fundamentals of tissue image analysis, alongside discussion of the applications of digital pathology in different therapeutic areas
  • Explore how Digital Pathology is being utilised in Oncology. Digital Pathology is currently a timely intervention in the field of oncology, and it can act as a checkpoint for immune therapy. Presentations consider how these new technologies enhance detection, segmentation, feature extraction and tissue classification within immune therapy
  • Gain insights into how digital image analysis tools are currently being used in biomarker development, translational research, diagnostic laboratories and drug development
  • Learn about the advantages and limitations of tissue analysis, with case studies on emerging concepts, such as artificial intelligence, machine learning and the integration of omic technologies

Agenda at a Glance

Digital Pathology In Biomarker Development And Translational Research

  • Digital Pathology and Multiplex Spatial Tissue Analysis
  • Digital Pathology and Image Analysis In Tissue Biomarker Research
  • Digital Pathology, Computational Imaging and Biomedical Research
  • Digital Pathology in Immuno-Oncology and Oncology Biomarker Development
  • Digital Pathology for Precision Medicine

Emerging Technologies In Digital Pathology

  • Integrating Digital Pathology with Omics Technologies
  • Leveraging on Big Data and Artificial Intelligence in Digital Pathology in Immunotherapy

Moving Digital Pathology Into The Clinic

  • Case studies for Healthcare and Pharma: Bridging the gaps between research, development and clinical uptake
  • Panel Discussion: Accelerating Clinical Deployment
    • Reflection of diagnostic work-flow and patient development
    • Bridging the gap between research and clinical update
    • Impact of digital pathology and artificial intelligence tools

This event is co-located with the virtual event 3rd Annual Advances in Immuno-Oncology USA Congress
and 5th Annual Biomarkers & Precision Medicine USA Congress.

Attendees will have full access to all 3 events.

Confirmed Speakers

The Symposium brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Zhiyong (Sean) Xie, Pfizer

Zhiyong (Sean) Xie

Pfizer

Michael Roehrl, Memorial Sloan Kettering Cancer Center

Michael Roehrl

Memorial Sloan Kettering Cancer Center, USA

Beatrice Knudsen, University of Utah

Beatrice Knudsen

University of Utah

Wasim Malik, Massachusetts General Hospital

Wasim Malik

Massachusetts General Hospital, USA

  • Trevor McKee, Image Analysis Core Facility Manager, Princess Margaret Cancer Centre, Canada
  • Mohamed Salama, Professor of Pathology and Laboratory Medicine, Mayo Clinic, Chief Medical Officer, Mayo Clinic Laboratories
  • Liron Pantanowitz, Professor of Pathology and Biomedical Informatics, UPMC
  • Iman Tavassoly, Physician-Scientist And Postdoc Research Fellow, Mount Sinai Institute For Systems Biomedicine And Systems Biology Center New York Of Mount Sinai Medical School

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual, remote experiences.

Virtual Presentations

Benefit from the insight of our expert speakers via live and pre-recorded presentations

Live Q&As

Interact with fellow attendees and speakers during the live Q&As at the end of each presentation

Digital Networking Opportunities

Connect directly with other registrants of event around the world